# Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry

> **NCT07354087** · — · ACTIVE_NOT_RECRUITING · sponsor: **Tata Memorial Hospital** · enrollment: 300 (actual)

## Conditions studied

- Endometrial Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07354087
- **Lead sponsor:** Tata Memorial Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2024-11-28
- **Primary completion:** 2026-11-27
- **Final completion:** 2026-11-27
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2026-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07354087

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07354087, "Impact of Molecular Pathological And Clinical Features for Adjuvant Treatment Selection in Endometrial Cancer: Asian Registry". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07354087. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*